What do organ transplants, pig genes, and electric helicopters all have in common?
To find out, join us for an extraordinary event featuring Dr. Martine Rothblatt, CEO of United Therapeutics and one of Forbes’ “100 Greatest Business Minds” of the last century, as our keynote speaker. Experience the remarkable journey of an entrepreneurial pioneer who founded a biotech company to save her young daughter’s life from a rare disease without approved treatments. Today, United Therapeutics boasts multiple FDA-approved life-saving medicines, and her daughter thrives.
Dr. Rothblatt’s innovative work continues to push boundaries. She recently led efforts to create pigs with ten engineered genes whose organs have been used in the first human xenotransplants; to create a 3D-printed lung of 44 trillion voxels that is said to be the most complex 3D printed object; to create a GMP supply of 500 lung scaffolds annually; and to deliver for the first time by drone a lung for a life-saving transplant.
Martine’s incredible accomplishments extend beyond biotech. A true polymath, she has bachelor’s, law, and MBA degrees from UCLA and a Ph.D. In Medical Ethics from the University of London – not to mention an honorary degree in 2019 from the University of Victoria. She is a helicopter and fixed-wing pilot with a Guinness World Record for the longest flight in an electric helicopter. She designs zero carbon footprint buildings, including the world’s largest, the Unisphere in Silver Spring, Maryland. She also revolutionized the broadcast industry by recognizing the untapped potential of satellite radio, leading her to establish the world’s first satellite mobile communication system and found SiriusXM Radio.
As an accomplished author, Martine has written thought-provoking books such as “Virtually Human,” exploring the realm of cyber-consciousness, and “Your Life or Mine,” delving into the fascinating field of xenotransplantation.
This was an exclusive opportunity to hear Martine Rothblatt share her incredible journey and ground-breaking insights.